Sepsis Clinical Trial
Official title:
The Correlation of Regional Cerebral Oxygen Saturation(rScO2) Variation in Passive Leg Raising (PLR) With Neurological Outcomes of Sepsis and Septic Shock Patients
Sepsis related cerebral dysfunction was underestimated in critical illness setting, and inflammatory response of brain could not be monitored directly and cerebral oximetry offered information of cerebral dysfunction. We had hypothesized cerebral oxygenation responsiveness during passive leg raising could in some way had association in predicting with the outcomes of septic shock.
Research question: Does increased regional cerebral oxygen saturation variation in passive
leg raising(PLR) associated with better neurological outcomes of sepsis and septic shock
patients?
Specific aims:
1. To stablish an algorithm to assess focal neurological dysfunction through regional
cerebral oxygen saturation(rScO2) of sepsis and septic shock patients
2. To assess the safety and gain some experiences evaluate cerebral oxygen in passive leg
raising and fluid expansion.
3. To test the correlation of rScO2 variation with neurological complication and prognosis
of septic shock patients.
Significance:
1. Sepsis and septic shock were associated with increased risk of mortality, elevated
morbidity rates, and neuro-developmental disability.
2. The definition of SEPSIS 3.0, signify qSOFA scores as a bedside prompt that may identify
patients with suspected infection who are at greater risk for a poor outcome, It uses
three criteria, including altered mentation (Glasgow coma scale<15).
3. Previously, sepsis related cerebral dysfunction was underestimated in critical illness
setting, and inflammatory response of brain, such as oxygen deficit of brain tissue
could not be monitored directly, thus cerebral oximetry monitoring could be used for the
evaluation of cerebral tissue oxygenation in real time, providing indirect information
of the brain function during sepsis and septic shock.
4. Length of reduced cerebral oxygen saturation was confirmed associated with worse outcome
after major surgery perioperatively. We hypothesized that cerebral oxygen metabolism was
degenerated during sepsis and septic shock, and lower cerebral oxygenation would have
somewhat correlations with worse outcome of sepsis and septic shock patients.
Study Design: This will be a observational cohort trial. The schematic diagram of the study
is as Figure 1. Subjects will be enrolled, and then be followed up. The outcome variables
will be recorded. Inclusion criteria were age above 18 either under 80 years, and diagnosed
with sepsis, using Sepsis 3.0 criteria.
Whereas exclusion criteria were patients who were under 18 or above 80 years, pregnant, brain
dead, severe head trauma, patients who had a difference more than 10% between the 2 probes of
cerebral oxygen saturation monitor due to possible unilateral focal pathology, and whose
cousins made decision to withdraw from resuscitation.
The baseline parameters of sepsis and septic shock patients are collected: demographic data
(age, sex, comorbidities, resources and diagnosis), Acute Physiology and Chronic Health
Evaluation (APACHE) II score (on admission and after 24 hours), hemo-dynamic parameters (mean
arterial pressure [MAP], heart rate, cardiac index [CI], stroke volume variation, and global
end-diastolic index using PICCO Monitor from Pulsion, Germany), serial lactic acid
measurements at presentation and after 48 hours, blood gases (arterial and central venous [at
presentation and every 8 hours]), and rScO2 (at presentation and every 8 hours). Delirium
were diagnosed using CAM-ICU criteria for delirium in ICU.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05095324 -
The Biomarker Prediction Model of Septic Risk in Infected Patients
|
||
Completed |
NCT02714595 -
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
|
Phase 3 | |
Completed |
NCT03644030 -
Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
|
||
Completed |
NCT02867267 -
The Efficacy and Safety of Ta1 for Sepsis
|
Phase 3 | |
Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
Recruiting |
NCT05578196 -
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
|
N/A | |
Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
Completed |
NCT03550794 -
Thiamine as a Renal Protective Agent in Septic Shock
|
Phase 2 | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Completed |
NCT03258684 -
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock
|
N/A | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Completed |
NCT05018546 -
Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery
|
N/A | |
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 |